Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis. - Wikidata - awgldk - TriplyDB

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

http://www.wikidata.org/entity/Q37333092

about

Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.Risk factors for linezolid-associated thrombocytopenia in adult patients.In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB Linezolid for treatment of chronic extensively drug-resistant tuberculosis.Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics New treatment options for multidrug-resistant tuberculosis.Linezolid for Treating Tuberculosis: A Delicate Balancing Act.Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis.Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients.Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment.Effect of linezolid on serum PCT, ESR, and CRP in patients with pulmonary tuberculosis and pneumonia

P2860

Q28540482-ADEF8DE7-5135-42F3-A47B-C79F21667132 Q33394332-F46CB4A8-71FA-4C89-B650-3C48547EACE3 Q33407349-B0105196-6997-4EED-9182-84C38A613703 Q33417036-2482AF68-E896-4A03-8C60-B6FF2B9D185B Q34591451-360AE8AD-DC10-4F6D-B3F6-DF75984AB488 Q34644127-5250E0FB-20C5-4C58-934F-01F7E806F321 Q36364155-E8418295-C8B8-4203-833A-E48F88BA3E7D Q36439105-AE0A711C-1F0E-41CE-9A86-7B226B84AA53 Q37712989-5B427684-056F-4CB7-B60C-E9DC2A4C4E62 Q38024041-E5ED36CE-4BDF-4873-9304-040435B4FA1F Q38255352-3344D8AD-F331-4D48-A7BA-72A618547B08 Q40110014-8EDA5D21-48FC-445F-8596-F0B8903796C6 Q42189998-1E50DE0F-D1E1-4EAC-8387-CBAE956B02AB Q42363645-D319699A-FD61-4828-A61F-1C1ED8508A74 Q42715629-B857B3FE-F61B-435E-AB54-616FC4B0BAA6 Q52584725-307275BF-81A7-466C-854F-50F4B9DB0FB0 Q53205517-F41F5925-4771-4897-8430-2D96966F1C44 Q58739743-C5BEDF33-C33A-4285-B77A-397BB94D380F

P2860

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

http://www.wikidata.org/entity/Q37333092

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

@en

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

@nl

type

label

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

@en

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

@nl

prefLabel

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

@en

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

@nl

P1433

Q37333092-E9DDCEE8-BA30-471E-BCBF-AB1CA8F05ACA

P1476

Q37333092-B4958885-FDB7-4985-AEB0-9C8D227B428D

P2093

Q37333092-1966C30F-B160-467A-917B-36BCFA6CB23C

Q37333092-510BDE10-D51F-4A1E-BCE3-BCDC95540F32

Q37333092-8808E9C9-53FD-4B92-977D-831D3F7066DA

Q37333092-8E33AF6F-BCEF-42C5-A915-99047AD3B5D2

Q37333092-9E19A82E-6DF1-4176-96A5-CC5B80BA145D

Q37333092-A2285291-FA35-49F3-9172-B34B5DEF5CF0

Q37333092-C729C1F8-BE1C-42B0-9978-97042C4BD506

P2860

Q37333092-050975CD-4012-4B47-B99E-7F81B48C14C8

Q37333092-2204E1CB-E7DC-4F2A-9D01-15E9B6B3698C

Q37333092-25241A36-94BC-4DEA-A229-8032CD2186CE

Q37333092-3C74CF50-A365-47C6-BF6E-237F5463C37B

Q37333092-4305BC4C-6ED4-46C6-B888-CC546B33118F

Q37333092-51E95C92-048F-41E8-955D-D50AEB905FB8

Q37333092-5DF6E16D-1540-465E-A3FC-7D51EDD6D584

Q37333092-79F20335-E290-4F82-B4DA-C46066B09457

Q37333092-AA081477-4282-4360-A17E-89C4F97113DD

Q37333092-B6E34758-CC5A-4593-A182-8850C7AAFE8D

P304

Q37333092-BB022E12-B4F4-439F-B909-7C430179FE72

P31

Q37333092-DD2139F0-5F98-4A50-B677-D363C4326582

P356

Q37333092-66C1C335-19BC-4EE8-AD71-6C48A8C83EF2

P407

Q37333092-363AED2E-56FB-4AE1-9B64-6EB01B775C9A

P433

Q37333092-9D9E588C-972A-432C-8FD0-233562BBDC27

P478

Q37333092-A1069135-28FB-4959-B10B-EE441272F9F4

P50

Q37333092-1711C72B-CB98-4D56-B008-149B39177CE9

Q37333092-FA0BC35F-829C-4AE3-A892-AB5ED3374210

P577

Q37333092-0F431ACF-8615-4128-A03E-CC22813675A1

P5875

Q37333092-51CA84DE-DC4D-40FE-BC05-B41830CDA4B7

P698

Q37333092-2D7A61A5-2683-4BA5-B552-DA13B65CE1C6

P921

Q37333092-D7EBE362-7C00-4B68-94A9-D2E137F3385E

P932

Q37333092-762CB1B3-7F43-4B65-950C-CBDFF195BAE4

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis

@en

P2093

Bryan McGee

http://www.w3.org/2001/XMLSchema#string

Charles A Peloquin

http://www.w3.org/2001/XMLSchema#string

David Jamil Hadad

http://www.w3.org/2001/XMLSchema#string

John L Johnson

http://www.w3.org/2001/XMLSchema#string

Lucilia Pereira Dutra Molino

http://www.w3.org/2001/XMLSchema#string

Moises Palaci

http://www.w3.org/2001/XMLSchema#string

W Henry Boom

http://www.w3.org/2001/XMLSchema#string

P2860

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.

Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.

Linezolid for the treatment of multidrug-resistant tuberculosis.

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs

Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.

Oxazolidinones: activity, mode of action, and mechanism of resistance.

Antimycobacterial activities of oxazolidinones: a review.

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

P304

3981-3984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01378-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Reynaldo Dietze

Ethel Leonor Noia Maciel

P577

2009-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26328385

http://www.w3.org/2001/XMLSchema#string

P698

19564361

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

2737850

http://www.w3.org/2001/XMLSchema#string